WHAT THIS PAPER ADDS This is the first published cohort study to demonstrate reduced expression of low-density lipoprotein receptorrelated protein 1 (LRP1) in abdominal aortic aneurysm (AAA) compared with normal control aortic tissues from humans, suggesting that a reduction in LRP1 protein expression may be associated with aneurysm progression. Our finding is novel as no study has been reported on the investigation of LRP1 protein expression in AAA and normal control aortic tissues from humans, although LRP1 gene has been suggested as a lead gene for AAA from a genome-wide association study.
INTRODUCTION
It is now more than 40 years since Clifton reported familial clustering of abdominal aortic aneurysm (AAA), 1 a phenomenon which is well-recognized by most vascular specialists. Patients who have relatives with AAA are more likely to be affected themselves. 2, 3 These observed facts have therefore led to a search for genetic predisposition responsible for AAA, to improve understanding of AAA pathogenesis, and to develop future management paradigms. 4 The inheritance of AAA is likely to be multifactorial. 5, 6 A handful of candidate gene association studies for AAA have been published but results are not always reproducible by different centres, as studies were underpowered and gave inconsistent results. 7 Some genes are consistently implicated, such as the single nucleotide polymorphisms in genes of the renin-angiotensin system and of folate metabolism, which are consistently associated with an increased risk of developing AAA. 8, 9 Two common genetic polymorphisms in transforming growth factor (TGF)-beta receptor were also found to be associated with AAA, although this association was mainly driven by findings in the Netherlands group and marked between-study heterogeneity was detected between patients from the Netherlands, New Zealand, and Western Australia. apolipoprotein(a) gene variants rs10455872 and rs3798220, which correlate with lipoprotein(a) levels and coronary artery disease. 11 Duellman et al. also found significant association between matrix metalloproteinase-9 (MMP-9) genotype and AAA. 12 Variation in the fibrillin-1 gene, which was found to be associated with an increase in arterial pulse pressure, was suggested to increase the risk of developing AAA. 13 Mutation in type III collagen (COL3A1) was also suggested to cause AAA. 14 One of the genes examined recently in AAA is the lowdensity lipoprotein receptor-related protein-1 (LRP1) gene. The protein encoded by the LRP1 gene is a cell surface receptor abundantly expressed in liver, lung, brain, intestine, and muscle. 15 The LRP1 protein is 600 kDa in size, comprising a 515 kDa extracellular fragment and a 85 kDa intracellular and intramembrane fragment.
15À17 This protein is classified as a member of the low-density lipoprotein receptor (LDLR) family because of the structural resemblance.
18À20 LRP1 not only shares structural homology with the other LDLR members, but also has the ability to bind to a diverse group of ligands for regulation of different cellular processes. 15, 17 LRP1 is suggested to be related to AAA as MMP-9, which is abundantly expressed in AAA tissues for degradation of extracellular matrix proteins, is reported to bind to LRP1. 15, 21, 22 Also, a knockout study showed that mice with depletion of LRP1 specifically in vascular smooth muscle cells appeared to have aneurysm formation with dilated aorta. 23 More recently, a genomewide association study reported that there is a significant association between a variant in the LRP1 gene and AAA, suggesting that the LRP1 gene may be a lead gene for AAA formation. 24 Although these studies suggested that LRP1 could be a crucial regulator of AAA formation, there is still no study directly examining LRP1 expression in aortic tissues from humans. The aim of this paper is to investigate the LRP1 expression in human aortas from Chinese patients with AAA, and to compare with normal control tissues.
MATERIALS AND METHODS

Collection of human abdominal aorta specimens
Our centre is a regional tertiary referral centre for vascular patients and also for patients undergoing organ transplantation. All relevant clinical data including demographics of patients for research analysis were obtained from the Hospital Authority's Clinical Medical System (CMS), which is a centralized computer database of patient records. All our subjects were of Chinese ethnicity. Consent for obtaining human specimen for research was obtained, and this project was approved by the local institution's ethics committee.
Full thickness aneurysmal infrarenal aortic samples were excised at the point of maximum aortic dilatation from 12 patients (mean age AE SD ¼ 74.00 AE 8.34; seven males and five females) during open surgical aneurysmal repair at our hospital. These patients were free from connective tissue disorders, that is Marfan syndrome and Ehlers Danlos syndrome. All 12 full thickness AAA specimens were used for western blotting, but only 10 of the 12 specimens were used for immunohistochemistry(IHC) as two specimens were so small in size that they were sufficient only for the western blotting.
For the normal control group, full thickness infrarenal abdominal aortas from 12 healthy organ donors (mean age AE SD ¼ 52.92 AE 13.60; five males and seven females) without known cardiovascular diseases or connective tissue disorders were dissected out during organ transplantation. All 12 normal control full thickness specimens were used for both western blotting and IHC.
Each of the aortic specimens collected was thoroughly washed with Dulbecco's modified eagle medium (DMEM) with 10% fetal bovine serum (FBS) (Life Technologies, Carlsbad, CA, USA) prior to dissection into two parts for different methods of research analysis, that is western blotting and IHC.
Western blotting
The LRP1 protein expression level in aortic specimens was analyzed and quantified by western blotting. Proteins from 100 mg aortic specimens, which was grinded to powder in liquid nitrogen in advance, were extracted by 1X radioimmunoprecipitation (RIPA) lysis buffer ( Horseradish peroxidase (HRP)-conjugated goat anti-rabbit or mouse IgG (Invitrogen, Carlsbad, CA, USA) at 1:10000 dilution was used in secondary antibody incubation for 1 hour at room temperature. Band intensity on X-ray film (Fujifilm, Tokyo, Japan) after ECL Prime detection system (GE Healthcare) was analyzed by Image J software (v1.46, National Institutes of Health, Bethesda, MD, USA). The protein band intensity was measured by cropping the band out for automatic detection of its brightness. The relative protein expression level of LRP1 of each specimen was achieved by the band intensity of LRP1 normalized with the band intensity of GAPDH, which served as a loading control. Furthermore, the protein expression levels of LRP1 in both groups, that is AAA and normal control, were normalized with that of the normal control group, representing the ratio of LRP1 AAA /LRP1 Normal Control and LRP1 Normal Control / LRP1 Normal Control respectively.
Immunohistochemistry (IHC)
The LRP1 protein expression in formalin-fixed and paraffinembedded aortic specimens was analyzed by IHC according to manufacturer's protocol (DakoCytomation, Glostrup, Denmark). The tissue section (6 mm thickness) was incubated at 4 C overnight with mouse monoclonal antibody
[8G1] against LRP1 (Abcam) at a concentration of 10 mg/mL in antibody diluent (DakoCytomation). Negative control was performed side by side using the same tissue section under the same conditions, but with antibody diluent alone during antibody incubation. HRP-labelled polymer-conjugated goat anti-mouse antibody (DakoCytomation) was used as secondary antibody incubation for 1 hour at room temperature. Liquid 3,3 0 -diaminobenzidine (DAB) þ substrate chromogen system (DakoCytomation) was applied for visualization, followed by counterstaining with Mayer's hematoxylin histological staining reagent (DakoCytomation). The slides were dehydrated and mounted with Permount mounting medium (Fisher Scientific, Hampton, NH, USA). Images of positive staining signal were captured by inverted microscope (Nikon Eclipses E600) (Nikon, Tokyo, Japan). Both AAA and normal control groups were tested to be normally distributed (p > .05) by ShapiroeWilk test (pvalue of AAA group ¼ .528; p-value of normal control group ¼ .355). Independent-samples Student t test was then used to investigate the statistical differences of LRP1 protein expression between AAA and normal control groups. The mean LRP1 protein expression level was expressed as mean AE SD.
Statistics
The investigation on the statistical relationship between the LRP1 protein expression and the AAA risk factors, that is age, gender, smoking, hypertension, diabetes, cardiac disease, pulmonary disease, renal disease, dyslipidemia, and presence of statin therapy, was done using a linear regression analysis. Correction for the factors of LRP1 expression was done using a linear model.
The correlation between the size of AAA and LRP1 protein expression level was analyzed by Pearson correlation coefficient test.
The level of significance was set at .05.
RESULTS
Patient characteristics
There were 12 AAA and 12 normal control aortic specimens collected from Chinese patients with AAA and healthy organ donors respectively. The demographic data of AAA patients and healthy organ donors in this study are listed in Table 1 .
Lower LRP1 protein expression in AAA than normal control aortic tissues LRP1 protein expression in 12 AAA and 12 normal control aortic tissues was investigated by western blotting. LRP1
proteins were detected in both AAA and normal control aortic tissues (Fig. 1 ). However, a reduced expression level of LRP1 protein was observed in AAA compared with normal control aortic tissues (Fig. 1A) (Fig. 1B) .
The observed expression pattern of LRP1 protein in AAA and normal control aortic tissues was validated by performing IHC on paraffin-embedded aortic tissue sections of 10 AAA and 12 normal control specimens. Positive staining (brown in colour) of LRP1 protein was detected in medial and adventitial regions of aortas from both AAA and normal control aortic tissues (Fig. 2) . However, relatively less positive staining of LRP1 protein was observed in AAA ( Fig. 2A ) than in normal control aortic tissue sections (Fig. 2B ). This suggests that the AAA tissue sections had a lower LRP1 protein expression than the normal control aortic tissue sections.
No effect of the risk factors on LRP1 protein expression
No significant relationship (p > .05) was found between LRP1 protein expression and all AAA risk factors, that is age, gender, smoking, hypertension, diabetes, cardiac disease, pulmonary disease, renal disease, dyslipidemia, and presence of statin therapy, by a linear regression analysis (Table 2) . Correction for the factors of LRP1 protein expression was made by using a linear model. The differential LRP1 expression between AAA and normal control groups was robust to correction for the factors in a linear model (p < .05).
No significant correlation between AAA size and LRP1 protein expression No significant correlation was shown between the size of AAA and LRP1 protein expression (p > .05) (Fig. 3) .
DISCUSSION
This is the first published cohort study to show a reduced expression level of LRP1 protein observed in AAA compared with normal control aortic tissues from humans. The normalized LRP1 protein expression level in AAA tissues was about half that of normal control aortic tissues, which was statistically significant. This result suggests that such a reduction in LRP1 protein expression in human aortic tissues is associated with AAA progression. Our finding is novel as no previous study has investigated LRP1 protein expression in human AAA and normal control aortic tissues in either Chinese or non-Chinese populations.
Our suggested association of reduced LRP1 expression with AAA progression may be in the same direction as a genome-wide association study of a Caucasian population. 24 Bown et al. showed that there is a significant association between a variant in the LRP1 gene and AAA, where such association is independent of risk factors for generalized cardiovascular disease. 24 Their study provides an insight that the lead single nucleotide polymorphism (SNP) of the LRP1 variant may have a role in AAA formation, possibly by altering LRP1 expression in aortic tissues.
Our finding was only that LRP1 protein expression is reduced in AAA tissues, the exact mechanism of how it is down-regulated is still unknown. We postulate that such down-regulation of LRP1 expression may be aided by microRNA (miR), which is known for gene silencing either by degradation of mRNA or repression of translation, as one microRNA, miR-205, is identified to regulate LRP1.
25e27 This miR-205 is identified to down-regulate LRP1 expression by inhibiting translation of LRP1 mRNA into proteins without affecting its mRNA level, which is in common with our observation of reduced LRP1 protein expression. 27 Therefore, it is hypothesized that miR-205 is overexpressed in AAA tissue in suppression of LRP1 translation, resulting in reduced LRP1 protein expression. Such a hypothesis could be validated by examining LRP1 mRNA expression in AAA and normal control aortic tissues by reverse transcriptionpolymerase chain reaction (RT-PCR), which is currently in process. The endogenous miR-205 expression in both aortic tissues will also be examined to see if miR-205 is overexpressed in AAA tissues.
Our suggested association of reduced LRP1 expression and AAA progression is in agreement with the knockout study using a mouse model performed by Boucher et al., as they found that mice with depletion of vascular smooth muscle-specific LRP1 showed aneurysm formation with dilated aortas. 23 Boucher et al. observed aneurysm formation after depletion of LRP1 in specifically vascular smooth muscle cell (VSMCs), 23 but it is still uncertain whether the observation in our study is specific to the VSMC cell type. Further validation could be done by performing immunofluorescence double staining on AAA and normal control tissue sections against LRP1 and VSMC markers, such as smooth muscle a-actin, in order to identify whether the reduced LRP1 expression in AAA compared with normal control tissues is VSMC-specific.
A very recent mouse model study by Muratoglu et al. also supports our hypothesis that reduced LRP1 protein expression may be associated with AAA progression as LRP1-knockout mice showed aortic dilatation with disorganized and degraded elastic lamina. 28 The suggested role of LRP1 in maintaining vascular wall integrity is postulated to work as posing an antagonistic effect on matrix metalloproteinases (MMPs), which are known enzymes for degradation of extracellular matrix (ECM) proteins in AAA, as a study using a mouse embryonic fibroblast cell line with LRP1 depletion showed a reduced ability of binding, internalization, and degradation of MMP-9.
21,29À32 It is hypothesized that the reduced LRP1 expression may result in a lower chance of internalization and degradation of MMP-9 in VSMCs, possibly resulting in a higher chance of ECM protein degradation and AAA progression. To testify such hypothesis, LRP1 is suggested to be overexpressed in VSMCs, followed by analysis of the efficiency of MMP-9 internalization and degradation in VSMCs.
The reduced LRP1 expression may be associated with AAA progression aided by the inflammatory process which is a known factor of AAA pathogenesis, as some studies reported that the levels of some inflammatory cytokines or mediators, such as tumour necrosis factor-a (TNF-a), monocyte chemoattractant protein type-1 (MCP-1), interleukin-6 (IL-6), and activated complement proteases, were increased in LRP1-deficient mouse models and cell lines.
33À36 Also, Overtan et al. showed that a higher frequency of fragmentation of elastic lamina occurred in the LRP1-deficient mice. 35 Analysis of the expression of inflammatory cytokines or mediators in AAA in comparison with normal control aortic tissues may help to identify whether any inflammatory response is present.
The proposed role of LRP1 in maintaining vascular wall integrity may work as posing an agonistic effect on a cholesterol export protein, ATP-binding cassette transporter A1 (ABCA1), which is identified for cholesterol efflux from cells and facilitation in high-density lipoprotein (HDL)-mediated removal of cholesterol from body. 37, 38 It is reported that depletion of LRP1 from VSMCs in a mouse model resulted in significant downregulation of ABCA1 expression, leading to reduced cholesterol efflux and an accumulation of excess cholesterol at the aortic wall. 37 The accumulation of cholesterol at the aortic wall is hypothesized to damage the vascular wall integrity, possibly increasing the chance of having AAA. Therefore, further investigation of whether ABCA1 expression is also reduced in AAA compared with normal control tissues is necessary.
Concerning the maintenance of vascular wall integrity with the help of cholesterol efflux from aortic wall, a protein known as cholesteryl ester transfer protein (CETP) is proposed to have anti-atherogenic activity as cholesterol efflux from atherosclerotic lesion is reduced when CETP is deficient. 39 Although such anti-atherogenic activity of CETP is postulated to help protect the aortic wall integrity and hence possibly result in a lower chance of AAA development, there is still no study reported on the involvement of CETP in AAA prevention, nor the relationship between CETP and LRP1. Therefore, investigation of endogenous CETP expression in AAA compared with normal control tissues is necessary. The question of whether CETP works cooperatively with LRP1 in prevention of AAA remains to be investigated.
A previous study reported that hepatic LRP1 expression was increased after endogenous hydroxymethylglutarylcoenzyme A (HMG co-A) reductase was inhibited by atorvastatin using in vitro and in vivo methods. 40 However, there is still no study investigating whether HMG co-A reductase inhibitor, statin, increases LRP1 expression in VSMCs of the aorta. As no significant relationship was shown between LRP1 expression in the aorta and statin in our study, further investigation with a larger sampling size is necessary.
This current study has some limitations. The major limitation is the relatively small sampling size. Because there is a growing trend for using endovascular aneurysm repair (EVAR) for aneurysmal repair rather than open surgery, where the AAA aortic samples are excised from patients, a limited amount of AAA samples were collected for study. Therefore, a further large-scale study recruiting more Chinese patients with AAA from different geographic areas of China would ascertain the current finding. Also, as our study is small-scale, the influence of the confounding risk factors, such as age, gender, smoking, hypertension, diabetes, cardiac disease, pulmonary disease, renal disease, dyslipidemia, and presence of statin therapy, may be small and hence our pilot study showed no significant effect of those risk factors on LRP1 expression. With the recruitment of more patients for a larger-scale study, the effect of the risk factors on LRP1 expression could be further validated. Also, our study did not show any significant correlation between the size of AAA and LRP1 protein expression, proposing that the size of AAA may not be a determining factor of LRP1 expression. A large-scale study could help validate whether LRP1 expression is independent of the size of AAA. Subgroup analysis of those with or without cardiovascular diseases may further support our finding that LRP1 modulation is specific to AAA formation. The experimental limitation of this study is the possibility of band saturation of western blot, although the condition was optimized by diluting the antibodies and reducing the exposure time. Further repeats in the future large-scale study incorporating the use of another LRP1 antibody and loading marker, such as b-actin, is necessary.
In summary, LRP1 protein expression was found to be significantly reduced in AAA when comparing with normal control aortic tissues in our small cohort from a Chinese population. No significant correlation was shown between the size of AAA and LRP1 expression. This pilot study suggests that the reduced LRP1 protein expression may be associated with AAA progression. A further large-scale study recruiting more Chinese patients with AAA should be conducted to ascertain this finding.
